Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2015, Article ID 934865, 4 pages
Case Report

Costello Syndrome with Severe Nodulocystic Acne: Unexpected Significant Improvement of Acanthosis Nigricans after Oral Isotretinoin Treatment

1Division of Dermatology, Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
2Miller School of Medicine, Department of Pediatric Dermatology, University of Miami, 1600 NW 10th Avenue, Rosenstiel Medical Science Building, Room 2023, Miami, FL 33136, USA

Received 1 November 2014; Accepted 23 February 2015

Academic Editor: Ozgur Cogulu

Copyright © 2015 Leelawadee Sriboonnark et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. W. Gripp and A. E. Lin, “Costello syndrome,” in GeneReviews [Internet], R. A. Pagon, M. P. Adam, T. D. Bird, C. R. Dolan, C.-T. Fong, and K. Stephens, Eds., University of Washington, Seattle, Wash, USA, 1993, View at Google Scholar
  2. F. Morice-Picard, K. Ezzedine, M.-A. Delrue et al., “Cutaneous manifestations in costello and cardiofaciocutaneous syndrome: rport of 18 cases and literature review,” Pediatric Dermatology, vol. 30, no. 6, pp. 665–673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Nguyen, R. L. Buka, B. J. Roberts, and L. F. Eichenfield, “Cutaneous manifestations of Costello syndrome,” International Journal of Dermatology, vol. 46, no. 1, pp. 72–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. H. Siegel, J. A. Mann, A. L. Krol, and K. A. Rauen, “Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development,” British Journal of Dermatology, vol. 166, no. 3, pp. 601–607, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Costello, “A new syndrome: mental subnormality and nasal papillomata,” Australian Paediatric Journal, vol. 13, no. 2, pp. 114–118, 1977. View at Google Scholar · View at Scopus
  6. B. Kerr, M.-A. Delrue, S. Sigaudy et al., “Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases,” Journal of Medical Genetics, vol. 43, no. 5, pp. 401–405, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. L. Darmstadt, B. K. Yokel, and T. D. Horn, “Treatment of acanthosis nigricans with tretinoin,” Archives of Dermatology, vol. 127, no. 8, pp. 1139–1140, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. N. J. Mork, G. Rajka, and J. Halse, “Treatment of acanthosis nigricans with etretinate (Tigason) in a patient with Lawrence-Seip syndrome (generalized lipodystrophy),” Acta Dermato-Venereologica, vol. 66, no. 2, pp. 173–174, 1986. View at Google Scholar · View at Scopus
  9. H. W. Walling, M. Messingham, L. M. Myers, C. L. Mason, and J. S. Strauss, “Improvement of acanthosis nigricans on isotretinoin and metformin,” Journal of Drugs in Dermatology, vol. 2, no. 6, pp. 677–681, 2003. View at Google Scholar · View at Scopus